Bank of America’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-4,000
Closed -$597K 7569
2015
Q3
$597K Buy
+4,000
New +$2.94M ﹤0.01% 4687

Bank of America's TTPH Position: Q3 2020 in Review

Bank of America sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q3 2020, closing a stake of 14,730 shares — an estimated $37K sold.

Bank of America first reported a position in TTPH in Q2 2013 and held it in 29 quarters. The position peaked at $1.4M in Q1 2014. 1 fund tracked by Wall St. Rank holds TTPH as of Q3 2020.

  • Bank of America reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
  • Bank of America sold 14,730 Tetraphase Pharmaceuticals, Inc. shares in Q3 2020, an estimated $37K.
  • Bank of America first reported a position in Tetraphase Pharmaceuticals, Inc. in Q2 2013 and held it in 29 quarters.
  • Bank of America's Tetraphase Pharmaceuticals, Inc. position peaked at $1.4M in Q1 2014.
  • 1 fund tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q3 2020.

Based on Bank of America's 13F filing for Q3 2020, filed 13 Nov 2020.